home All News open_in_new Full Article
COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year
COSCIENS Biopharma Inc. (NASDAQ:CSCI, TSX:CSCI) announced a possible delay in filing its year-end reporting documents, including financial statements, CEO/CFO certifications, and annual information form, beyond the March 31, 2025 deadline due to complexities arising from the 2024 merger with Ceapro Inc. and identified material weaknesses in its financial controls. The company has applied for a management cease trade order and is working with auditors to complete the filings as soon as possible.
today 17 h. ago attach_file Other
attach_file
Other
attach_file
Politics
attach_file
Economics
attach_file
Other
attach_file
Economics
attach_file
Economics
attach_file
Culture
attach_file
Sport
attach_file
Economics
attach_file
Economics
attach_file
Politics
attach_file
Other
attach_file
Culture
attach_file
Economics
attach_file
Other
ID: 144653722